Healthcare around the world depends on the production of pure biopharmaceuticals. To be effective, those purification processes must be fast, robust, and affordable. By using non-affinity-based ...

Depending on the process and who provides the statistics, downstream processing accounts for between 50–80% of the cost of producing biotech drugs. Whatever the exact number, protein purification ...

Waters Corporation today announced the launch of the BioResolve ™ Protein A Affinity Columns with MaxPeak ™ Premier Technology, providing precise titer measurements. This launch marks the first set of ...

Creative BioMart, a professional life science research service supplier, has rolled out an updated version of its membrane protein expression and purification service suite, catering to the growing ...